Pemphigus vulgaris - still a difficult disease to treat

International Journal of Dermatology

Volumn 49, Issue 2, 2010, Pages 230-232

  Menezes, Nuno ^a   Leite, Inês ^a   Tente, David ^b   Couceiro, António ^b   Baptista, Armando ^a   Varela, Paulo ^a  

^a Serviço de Dermatologia do Centro Hospitalar   (Portugal)

^b CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DESMOGLEIN 1 ANTIBODY; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ABSENCE OF SIDE EFFECTS; ADULT; BLISTER; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LETTER; MALE; MOUTH DISEASE; MULTIPLE CYCLE TREATMENT; PEMPHIGUS VULGARIS; RELAPSE; TRUNK;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; AZATHIOPRINE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFUSIONS, INTRAVENOUS; MALE; MYCOPHENOLIC ACID; PEMPHIGUS; PREDNISONE; RETREATMENT; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 74949116365     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04192.x     Document Type: Letter

References (6)

1. Ahmed AR. Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy. Expert Opin Investig Drugs 2004, 13:1019-1032.
2. Rastetter W, Molina A, White CA. Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Annu Rev Med 2004, 55:477-503.
3. Salopek TG, Logsetty S, Tredget EE. Anti- CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, lifethreatening pemphigus vulgaris with implications in the pathogenesis of the disorder. J Am Acad Dermatol 2002, 47:785-788.
4. Hertl M, Zillikens D, Borradori L. Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases. J Dtsch Dermatol Ges 2008, 6:366-373.
5. El Tal AK, Posner MR, Spigelman Z, Ahmed AR. Rituximab: A monoclonal antibody to CD 20 used in the treatment of pemphigus vulgaris. J Am Acad Dermatol 2006, 55:449-459.
6. Chaiwatanatorn K, Lee N, Grigg A. Delayed-onset neutropenia associated with rituximab therapy. Br J Haematol 2003, 121:913-918.